	Piezo1-A Key Pathogenic Factor in Breast Implant-Associated Capsular Contracture. Aesthetic Plast Surg Sun JM, Liu YX, Zheng DN, Cai YC, Zhang YF, Yu L. PMID: 41559393 [PubMed - as supplied by publisher]
	CDK4/6 Inhibition in the Management of Metastatic HR+/HER2+ Breast Cancer: Systematic Review and Meta-analysis. Target Oncol Park D, Varda M, Yeremian S, Hwang A, Huang C. PMID: 41559355 [PubMed - as supplied by publisher]
	From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer. Sci Rep Badukle H, Jawarkar RD, Shah U, Chaudhary S, Alzahrani AYA, Samad A, Al-Hussain SA, Al-Mutairi AA, Zaki MEA. PMID: 41559139 [PubMed - as supplied by publisher]
	Management and complication investigation among breast cancer patients undergoing immediate implant-based breast reconstruction: A Chinese multicenter study (CSBrS-012). Chin Med J (Engl) Li L, Zheng A, Jin F, Guo B, Chen B, Chinese Society of Breast Surgery. PMID: 41558971 [PubMed - as supplied by publisher]
	Reconstructive surgery and immigration status among females with breast cancer. Can J Surg Lovrics O, Kirkwood D, Coroneos CJ, Pond G, Hodgson N, Doumouras AG, Bogach J, Levine M, Parvez E. PMID: 41558773 [PubMed - indexed for MEDLINE]
	Metabolic signatures and predictive biomarkers of liposomal doxorubicin-induced hypersensitivity in breast cancer: A pilot study. Cancer Treat Res Commun Su X, Weng Y, Xiao Y, Weng L, Zeng Y, Lin W, Zhuang W. PMID: 41558225 [PubMed - as supplied by publisher]
	National survey of thromboprophylaxis management and tranexamic acid utilization in patients undergoing non-free flap breast surgery. J Plast Reconstr Aesthet Surg Haas J, Zhou T, Yuen K, Retrouvey H, Douketis J, Ghumman A. PMID: 41558155 [PubMed - as supplied by publisher]
	Basic and combined peripheral biomarkers have no predictive and prognostic value in breast cancer patients undergoing pre-operative systemic therapy. Cir Cir Karaali C, Esin H, Pala EE, Keser M, Unal OU, Ureyen O, Emiro. PMID: 41558046 [PubMed - indexed for MEDLINE]
	Validation and limitations of the distress thermometer in identifying depression among metastatic breast cancer patients in Nigeria: Methodological challenges in depression-specific screening validation. PLoS One Chavda T, Lawal A, Sowunmi A, Adegboyega B, Alabi A, Chung CC, Shirima S, Conserve DF, Bamodu OA. PMID: 41557711 [PubMed - indexed for MEDLINE]
	Zwitterionic molecularly imprinted polymers for selective capillary microextraction of N1,N12-Diacetylspermine (DiAcSpm) from breast cancer. PLoS One Ying K, Xue H, Du S, Wang X, Lei X. PMID: 41557635 [PubMed - indexed for MEDLINE]
	Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US. JAMA Netw Open Alagoz O, Lu Y, Gil Quessep E, Kerlikowske K, Mandelblatt JS, Sprague BL, Trentham-Dietz A, Hampton J, Groeneweg R, de Koning HJ, Miglioretti DL, Schechter CB, van Ravesteyn NT, Tosteson ANA, Stout NK, Lowry KP. PMID: 41557352 [PubMed - indexed for MEDLINE]
	Exosomal crosstalk between breast cancer cells and tumor-associated macrophages: mechanisms and therapeutic implications. Mol Biol Rep Gong RQ, Xu A, Huang X, Fu D. PMID: 41557096 [PubMed - in process]
	Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy. Breast Cancer Res Treat Pedersini R, Moretti L, Laganà M, Schivardi G, Baluta V, Zamparini M, Conforti E, Ravanelli M, Brentegani C, Amoroso V, Grisanti S, Buizza C, Scartabellati G, Bazzoli M, Ippolito G, Pellicioli F, Farina D, Berruti A, Cosentini D. PMID: 41557073 [PubMed - indexed for MEDLINE]
	Response to letter to the editor: Risk of endometrial cancer among breast cancer survivors in Japan-a matched cohort study. Breast Cancer Kawamura C, Iwagami M. PMID: 41557052 [PubMed - as supplied by publisher]
	Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study. Breast Cancer Res Treat Stabellini N, Kaur J, Owusu C, Moftakhar B, Mizukami T, de Oliveira SD, Montero AJ. PMID: 41557039 [PubMed - indexed for MEDLINE]
	Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. Breast Cancer Res Treat Alonso-Romero JL, Martínez-García J, Carrillo-Vicente R, Aramburo AF, Díez AF, Henarejos PS, de la Morena Barrio P, Boix AP, Jiménez MD, Siles JP, Maestre JAP, de Las Heras-Rubio A, Carreño PR. PMID: 41557021 [PubMed - indexed for MEDLINE]
	Integrated multi-omics identifies MCRS1 as a causal hub linking aging, metabolic syndrome, and breast cancer progression. Int J Surg Tao Y, Ding X, Xuan W, Zhu H, Liu X, Chen Y, Wu J, Du J, Tian J, Qian G. PMID: 41556158 [PubMed - as supplied by publisher]
	Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Randomized, Phase II Study. MedComm (2020) Huang J, Wang H, Tong Y, Hong J, Zhu Y, Ren W, Yu J, Shi H, Gao W, Zhu S, Wu J, Huang O, Li J, He J, Chen W, Li Y, Shen K, Chen X. PMID: 41556040 [PubMed]
	Potential Targets and Biomarkers of Radionuclide Therapy in Breast Cancer. Cancer Innov Tan Y, Zeng C, Wang J, Ma F. PMID: 41555955 [PubMed]
	Maternal Obesity and MicroRNAs in Breast Milk: Implications for Infant Developmental Programming. Obes Rev Santos GM, de Souza FIS, Pisani LP. PMID: 41555688 [PubMed - as supplied by publisher]

Articles 1 - 20 / 213747

Page 1 of 10688



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy